ANDA 74764, held by Bedford. Ranitidine Hydrochloride.
As of Nov 15, 2026, ANDA 74764 (Ranitidine Hydrochloride), held by Bedford, was first approved by FDA on Nov 19, 2004, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 19, 2004 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Ranitidine HydrochlorideEQ 25MG BASE/ML ยท injectable;injection | Ranitidine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
